Palliative management of malignant bowel obstruction

Area of Science:

• Gynecologic Oncology
• Gastroenterology
• Oncology

Background:

• Malignant bowel obstruction (MBO) is a recognized complication in patients with intra-abdominal and pelvic malignancies.
• It can present as a primary diagnosis or a recurrence following cancer therapy.
• MBO is particularly prevalent in advanced gynecologic cancers.

Purpose of the Study:

• To review the incidence and significance of malignant bowel obstruction in gynecologic oncology.
• To highlight the risk factors associated with MBO in gynecologic cancer patients.
• To emphasize the impact of MBO on mortality in ovarian cancer.

Main Methods:

• Review of retrospective and autopsy studies.
• Analysis of data from gynecological oncology services.
• Examination of patient demographics and tumor characteristics.

Main Results:

• Malignant bowel obstruction (MBO) occurs in 5-51% of gynecologic malignancy patients.
• Ovarian cancer patients experience MBO frequently, often as the primary cause of death.
• Advanced stage (III-IV) and high-grade ovarian tumors increase MBO risk.

Conclusions:

• Malignant bowel obstruction (MBO) is a critical issue in gynecologic oncology, especially for ovarian cancer.
• Early identification of high-risk patients is essential for management.
• MBO significantly impacts survival and quality of life in advanced gynecologic malignancies.